Principal Investigator
Frances Valdes
Enrollment Status
Open
Clinical Trial ID
Institutional Protocol #
20231043
Clinical Trial Summary
NRG-BR009: A Phase III Adjuvant Trial Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression plus Endocrine Therapy in Premenopausal Patients with pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score 25 (OFSET)
Phase
Phase III
Funding Agency/Sponsor
National Cooperative Group
Disease
Breast Cancer
Contact Information
Phone Number
+1 (305) 2439731